Dr. Toyos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6465 N Quail Hollow Rd Ste 100
Memphis, TN 38120Phone+1 901-683-7255Fax+1 901-683-3523
Education & Training
University of Missouri-Kansas City School of MedicineResidency, Ophthalmology, 1996 - 1999- University of Missouri-Kansas City School of MedicineInternship, Internal Medicine, 1995 - 1996
LSU School of Medicine in ShreveportClass of 1995
Certifications & Licensure
NY State Medical License 2019 - 2026
MS State Medical License 2020 - 2025
TN State Medical License 2014 - 2025
MO State Medical License 1996 - 2015
KS State Medical License 1999 - 2014
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Clinical Outcomes and Evaluation of Lotemax 0.5% in Treatment of Ocular Inflammation Associated With Cataract Surgery Start of enrollment: 2011 Apr 01
- Efficacy and Safety of Meibomian Gland Dysfunction and Dry Eye With an LED Blue Treatment Device Start of enrollment: 2019 Feb 12
Publications & Presentations
PubMed
- 1 citationsLetter to the Editor Re "Multicenter Study of Intense Pulsed Light Therapy for Patients With Refractory Meibomian Gland Dysfunction".Melissa M Toyos
Cornea. 2019-05-01 - 4 citationsComparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing PhacoemulsificationMelissa M. Toyos
Ophthalmology and Therapy. 2019-03-13 - 11 citationsDifluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies.John D. Sheppard, C. Stephen Foster, Melissa Toyos, Kerry L. Markwardt, Robert Da Vanzo
Ocular Immunology and Inflammation. 2019-01-01
Press Mentions
Taking Care of Your Eyes in the Golden Age of Screen TimeJanuary 19th, 2021
Dompé Announces First Patient Enrollment in Phase 2b Clinical Trial Investigating Novel Mechanism of Action in Moderate to Severe Dry Eye DiseaseJune 25th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
